Last edition
News about Ingredients
Eisai completes FDA submission for weekly subcutaneous LEQEMBI autoinjector
Eisai has completed the rolling submission of its Supplemental Biologics License Application (sBLA) to the US Food and Drug Administration for LEQEMBI IQLIK, a once-weekly subcutaneous autoinjector formulation of lecanemab-irmb (LEQEMBI), following the FDA’s Fast Track designation.
Ingredients | 27/11/2025 | By Darshana | 170
Lupin Manufacturing Solutions Commissions Dedicated Oncology Block at Vizag Facility
Lupin Manufacturing Solutions (LMS), a wholly owned subsidiary of global pharma major Lupin, has commissioned a dedicated oncology manufacturing block at its Vizag facility in India.
Ingredients | 12/11/2025 | By Dineshwori | 369
Valiant Advanced Sciences Begins Commercial Operations at New Greenfield Facility in Gujarat
According to Valiant Advanced Sciences, the new plant is dedicated to the production of Acetic Anhydride, a key chemical in the Ketene and Diketene derivatives category, serving both domestic and international markets.
Ingredients | 07/11/2025 | By Dineshwori | 356
Cambridge Isotope Laboratories (CIL), a subsidiary of Otsuka Pharmaceutical (Japan), has launched ISOAPI-D, a unified brand of deuterated intermediates for active pharmaceutical ingredient (API) synthesis, at CPhI Frankfurt.
Ingredients | 29/10/2025 | By Dineshwori | 222
Genenta Science and Anemocyte expand collaboration to advance off-the-shelf LVV Plasmid DNA platform
Genenta Science, a pioneer in immuno-oncology, and Anemocyte, a leading provider of advanced therapy and nucleic acid solutions, have announced an expanded strategic collaboration focused on developing an off-the-shelf lentiviral vector (LVV) Plasmid DNA technology platform.
Ingredients | 27/10/2025 | By Darshana | 252
AMSBIO Unveils New Range of Cytokines Tailored for Organoid and Stem Cell Studies
AMS Biotechnology (Amsbio) has introduced a new range of over 30 independently developed and manufactured organoid culture-related cytokines for researchers working with stem cells and induced pluripotent stem cells (iPSCs).
Ingredients | 14/10/2025 | By Dineshwori | 301
Hikal Launches New High Potency API Laboratory at its Pune Integrated Innovation Centre
Hikal has inaugurated an advanced High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at its Integrated Innovation Centre in Pune, further strengthening its end-to-end CDMO capabilities and enhancing its ability to safely develop, test and deliver highly potent compounds for the global pharmaceutical industry.
Ingredients | 14/10/2025 | By Dineshwori | 404
Hikal Opens New High Potency API Lab in Pune
Hikal Ltd., a preferred long-term partner to leading global life sciences companies, has inaugurated its state-of-the-art High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory at the company’s Integrated Innovation Centre in Pune.
Ingredients | 13/10/2025 | By Darshana | 335
Lonza Expands TheraPEAK Product Portfolio, Launches AmpliCell Cytokines and TheraPEAK 293-GT Medium
Switzerland-based Lonza has expanded its GMP solutions for cell and gene therapy with the launch of TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium.
Ingredients | 07/10/2025 | By Dineshwori | 255
Promocell Enters GMP Field with Launch of Custom Cell Culture Media Services
PromoCell GmbH has announced its entry into the Good Manufacturing Practice (GMP) field with the launch of custom cell culture media services designed specifically for cell-based therapy and regenerative medicine.
Ingredients | 01/10/2025 | By Dineshwori | 288
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy